AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1782776
Drug: Topical autologous
RxNorm normalized name: Autologous cultured fibroblasts
DrugBank: Azficel-T (DB11051)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical autologous plasma fibronectin, given 5 times per day for 11 weeks.
Trial: 19574176
Drug: Calcium (1,000
RxNorm normalized name: calcium carbonate 390 mg calcium (1,000 mg) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium (1,000 mg) and Vitamin D (400 IU)
Trial: 19574176
Drug: Calcium (1,000
RxNorm normalized name: calcium carbonate 390 mg calcium (1,000 mg) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium (1,000 mg) and Vitamin D (400 IU) plus Metformin (1,500 mg)
Trial: 30518693
Drug: Metformin (1,500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (1,500 mg)
Trial: 17291216
Drug: MMF stop
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MMF stop group (reduced and then stopped MMF dose)
Trial: 17291216
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (continued tacrolimus/MMF/steroids triple regimen)
Trial: 12466028
Drug: S-adenosyl-L-methionine (SAMe)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-adenosyl-L-methionine (SAMe) 400 mg/d intramuscularly
Trial: 12466028
Drug: Imipramine (IMI)
DrugBank: Imipramine (DB00458)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Imipramine (IMI) 150 mg/d orally
Trial: 8567842
Drug: Two layer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two layer Percoll gradient (1 ml semen layered on 36 and 81% Percoll gradient)
Trial: 8567842
Drug: SpermPrep II
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SpermPrep II method (1 ml semen run through SpermPrep II column)
Trial: 7306434
Drug: Terbutaline (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline (2.5 and 5 mg)
Trial: 7306434
Drug: Clenbuterol (larger
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clenbuterol (larger doses)
Trial: 15491244
Drug: Citalopram plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram plus mirtazapine (15-30 mg/day)
Trial: 9157451
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (daily 40 mg prednisolon i.v., 2 x theophylline i.v., 3 x inhalation of beta 2+ parasympathicolytic)
Trial: 29024499
Drug: Men's Club
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Men's Club intervention (5-hour interactive educational intervention + weekly text message reminders for 6 weeks)
Trial: 24612659
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with solifenacin 5 mg and mirabegron (various doses)
Trial: 24612659
Drug: Solifenacin 5
RxNorm normalized name: solifenacin 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solifenacin 5 mg monotherapy
Trial: 23007324
Drug: AR-GG27® cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AR-GG27® cream (sorbityl furfural palmitate)
Trial: 20398559
Drug: Drug intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Drug intervention group (hydrochlorothiazide, nitrendipine, and captopril)
Trial: 20398559
Drug: Drug intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Drug intervention group
Trial: 10447620
Drug: Conventional Pain
RxNorm normalized name: Dermoplast Pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional Pain Therapy (CPT) with tramadol (oral or intramuscularly) or piritramid intravenously
Trial: 23631443
Drug: Coadministration of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coadministration of metformin and RE
Trial: 17284576
Drug: Stavudine, 30-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stavudine, 30-40 mg, twice a day for 1 month
Trial: 12823645
Drug: Raloxifene 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene 150 mg day‐1
Trial: 12823645
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine oestrogen (CEE) 0.625 mg day‐1
Trial: 10195186
Drug: Vagus nerve
RxNorm normalized name: SUS SCROFA VAGUS NERVE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vagus nerve stimulation administered after learning
Trial: 8585003
Drug: Control cycle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control cycle without injection
Trial: 304984
Drug: 500 ml
RxNorm normalized name: TPN Bag 500 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 ml of dextran 60 intraoperatively (group A)
Trial: 304984
Drug: 100 ml
RxNorm normalized name: PVC IV Bag 100 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 ml dextran 60 on days 1 to 5 after operation (group B)
Trial: 18547128
Drug: IR methylphenidate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IR methylphenidate (Rubifen) 52.1 mg (SD = 13.8 mg) three times daily for 3 months
Trial: 18547128
Drug: OROS methylphenidate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OROS methylphenidate (Concerta) 57.9 mg (SD = 16.5 mg) once daily after switch
Trial: 16177676
Drug: Carvedilol treatment
RxNorm normalized name: Carvedilol
DrugBank: Carvedilol (DB01136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carvedilol treatment (Group I, n=32)
Trial: 16177676
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (Group II, n=27)
Trial: 11901392
Drug: Cortisone injection
RxNorm normalized name: hydrocortisone Injection
DrugBank: Cortisone (DB14681)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cortisone injection into the tendon sheath
Trial: 7768585
Drug: Losartan potassium
RxNorm normalized name: Losartan Potassium
DrugBank: Losartan (DB00678)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Losartan potassium 10 mg
Trial: 7768585
Drug: Losartan potassium
RxNorm normalized name: Losartan Potassium
DrugBank: Losartan (DB00678)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Losartan potassium 100 mg
Trial: 7768585
Drug: Losartan potassium
RxNorm normalized name: Losartan Potassium
DrugBank: Losartan (DB00678)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Losartan potassium 150 mg
Trial: 7768585
Drug: Enalapril maleate
RxNorm normalized name: Enalapril Maleate
DrugBank: Enalapril (DB00584)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Enalapril maleate 20 mg
Trial: 2186523
Drug: TD group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TD group (Aza added to continued low-dose CsA and prednisone)
Trial: 21323289
Drug: Ropivacaine 24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 24 mg plus morphine 8 mg (group R+M)
Trial: 21323289
Drug: Ropivacaine 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 40 mg (group R)
Trial: 21323289
Drug: Ropivacaine 36
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 36 mg plus ketoprofen 100 mg (group R+K)
Trial: 10740573
Drug: Larva therapy
RxNorm normalized name: Bombyx mori larva preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Larva therapy (LT)
Trial: 1441873
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine 5 mg (Group 2)
Trial: 22531485
Drug: 5% Lidocaine
RxNorm normalized name: LIDOCAINE 5 g in 100 g TOPICAL CREAM [Healcome Tattoo Numbing Cream 5% Lidocaine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% Lidocaine patch
Trial: 26484869
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Treatment plus Contingency Management (CBT + CM)
Trial: 12572358
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg Ca supplementation per day
Trial: 8667133
Drug: Saline group,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline group, irrigation with 2 cc of 0.85% saline
Trial: 8667133
Drug: Tetracycline group,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetracycline group, irrigation with 2 cc of aqueous tetracycline HCl, 50 mg/ml (5%)
Trial: 8667133
Drug: Chlorhexidine group,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorhexidine group, irrigation with 2 cc of chlorhexidine
Trial: 30992093
Drug: ACT-based lifestyle
RxNorm normalized name: ACT-101
DrugBank: ACT-101 (DB17000)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACT-based lifestyle modification treatment
Trial: 28629828
Drug: Prosthesis treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prosthesis treatment
Trial: 26519020
Drug: Exercise intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exercise intervention (walking and running for 25 minutes twice/week for 10 weeks at intensity corresponding to individual's ventilatory threshold)
Trial: 9256222
Drug: Abciximab bolus
RxNorm normalized name: Abciximab
DrugBank: Abciximab (DB00054)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Abciximab bolus plus infusion
Trial: 12854176
Drug: Heparin/low molecular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin/low molecular weight heparin (LMWH) treatment
Trial: 10363737
Drug: ketorolac tromethamine
RxNorm normalized name: Ketorolac Tromethamine
DrugBank: Ketorolac (DB00465)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ketorolac tromethamine 0.5% ophthalmic solution
Trial: 8489449
Drug: PhXA41 (0.006%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PhXA41 (0.006% solution, approximately 2 micrograms per treatment)
Trial: 2812914
Drug: Ceftriaxone (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone (80 mg/kg body weight, intramuscularly, once daily for 5 days)
Trial: 2812914
Drug: Chloramphenicol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloramphenicol (50 to 100 mg/kg body weight, orally, divided into 4 doses for 3 weeks)
Trial: 29574484
Drug: Solifenacin (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solifenacin (5 mg, once daily)
Trial: 23187965
Drug: Teduglutide (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teduglutide (10 mg, subcutaneously administered)
Trial: 17012860
Drug: DTPw‐HBV/Hib vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTPw‐HBV/Hib vaccine
Trial: 11240031
Drug: Circulating levels
RxNorm normalized name: peanut allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Circulating levels of soluble forms of adhesion molecules (sICAM-1 and sVCAM-1)
Trial: 9210689
Drug: Cefdinir (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefdinir (300 mg twice daily for 10 days)
Trial: 1656740
Drug: Cefaclor (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefaclor (500 mg three times daily for 10 days)
Trial: 3614956
Drug: 0.11 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.11 mg/kg diazepam
Trial: 3614956
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of diazepam and fentanyl doses
Trial: 29268206
Drug: Bright light
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bright light therapy (BLT) 10000lx
Trial: 27282265
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg esomeprazole plus 300 mg rebamipide daily (combination therapy group)
Trial: 27282265
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg esomeprazole daily (monotherapy group)
Trial: 20093623
Drug: Red wine
RxNorm normalized name: Red wine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red wine (RW) 100 mL daily for 3 weeks
Trial: 20093623
Drug: Water (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water (100 mL) daily for 3 weeks
Trial: 20093623
Drug: Beer (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beer (250 mL) daily for 3 weeks
Trial: 20093623
Drug: Vodka (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vodka (30 mL) daily for 3 weeks
Trial: 16195036
Drug: Physical activity
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical activity and ibuprofen (combination)
Trial: 9863122
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese medicine of replenishing Qi and nourishing Yin (RQNY) combined with a small dosage of Tapazol
Trial: 9863122
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (TCM + Tapazol)
Trial: 9863122
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine (Tapazol)
Trial: 3815397
Drug: Intranasal (IN)
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal (IN) 10 mg
Trial: 3815397
Drug: Intranasal (IN)
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal (IN) 5 mg
Trial: 3815397
Drug: Oral (PO)
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral (PO) 10 mg
Trial: 3815397
Drug: Intramuscular (IM)
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular (IM) 5 mg
Trial: 23764005
Drug: Tinzaparin 175
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tinzaparin 175 IU/kg once daily for 6 months
Trial: 23764005
Drug: Initial tinzaparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Initial tinzaparin 175 IU/kg once daily for 5-10 days and dose-adjusted warfarin (target INR 2.0-3.0) for 6 months
Trial: 19265308
Drug: Hand acupuncture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hand acupuncture therapy (including hand acupuncture and press-pellets based on corresponding points)
Trial: 16325440
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of racemic albuterol from dry powder inhalers
Trial: 11726410
Drug: Hyperbaric bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric bupivacaine 4 mg
Trial: 11726410
Drug: Hyperbaric bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric bupivacaine 6 mg
Trial: 9743164
Drug: Maxair Autohaler
RxNorm normalized name: Maxair Autohaler
DrugBank: Pirbuterol (DB01291)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Maxair Autohaler (1,200 microg pirbuterol) plus saline solution by nebulizer
Trial: 9743164
Drug: Placebo by
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo by Autohaler plus 2,500 microg albuterol via nebulizer
Trial: 7522415
Drug: Neoadjuvant total
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant total androgen ablation therapy (3 months of goserelin acetate and flutamide)
Trial: 3381269
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (corticosteroids/Leukeran)
Trial: 28684357
Drug: A‐Helping‐Hand (AHH)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: A‐Helping‐Hand (AHH) intervention with 6 weekly psychoeducational sessions and boosters
Trial: 22551128
Drug: Low-dose radioiodine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose radioiodine
Trial: 22551128
Drug: High-dose radioiodine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose radioiodine
Trial: 24997645
Drug: Low-dose radioiodine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose radioiodine (pT2-4 cancer)
Trial: 24997645
Drug: High-dose radioiodine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose radioiodine (pT2-4 cancer)
Trial: 24997645
Drug: Low-dose radioiodine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose radioiodine (total thyroidectomy)
Trial: 24997645
Drug: High-dose radioiodine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose radioiodine (total thyroidectomy)
Trial: 24997645
Drug: Low-dose radioiodine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose radioiodine (thyrotropin α stimulation)
Trial: 24997645
Drug: High-dose radioiodine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose radioiodine (thyrotropin α stimulation)
Trial: 24997645
Drug: Moderate-dose radioiodine
RxNorm normalized name: Radioiodine
DrugBank: Iodide I-131 (DB09293)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate-dose radioiodine
Trial: 19366274
Drug: Frovatriptan once
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Frovatriptan once daily (day 1: 5 mg; days 2-6: 2.5 mg)
Trial: 19366274
Drug: Frovatriptan twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Frovatriptan twice daily (day 1: 5 mg [10 mg total]; days 2-6: 2.5 mg [5 mg total])
Trial: 15290418
Drug: Intrathecal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal morphine (0.5 mg) + noradrenaline (5 micro g)
Trial: 31884409
Drug: Nasal mask
RxNorm normalized name: sulfur
DrugBank: Octasulfur (DB09353)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nasal mask combined with oral shield device (NMS)
Trial: 17616259
Drug: THEME (Update
FDA approved: no
EMA approved: no
PMDA approved: no
Description: THEME (Update day plus 12 weekly worksheets, feedback to audiotaped sessions, and three 30 minute sessions of telephone coaching)
Trial: 12377405
Drug: Nicotine 21
RxNorm normalized name: NICOTINE 21MG/24HR PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine 21 mg transdermal patch
Trial: 10203379
Drug: Interleukin (IL)‐2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interleukin (IL)‐2 therapy
Trial: 8880837
Drug: Inflammatory mediators
RxNorm normalized name: Arthriten Inflammatory Pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inflammatory mediators (IM) injected in acidic solution (BK, 5-HT, HIS, PGE2) at concentrations of 10(-7) M, 10(-6) M, and 10(-5) M.
Trial: 8880837
Drug: Negative control:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Negative control: IM in neutral solution injected into normal skin continuously infiltrated with buffer solution at pH 7.4.
Trial: 23429588
Drug: combination treprostinil
RxNorm normalized name: Treprostinil
DrugBank: Treprostinil (DB00374)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: combination treprostinil diolamine and sildenafil
Trial: 17320023
Drug: Intravenous ibandronate
RxNorm normalized name: ibandronate
DrugBank: Ibandronate (DB00710)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ibandronate
Trial: 11713443
Drug: Omeprazole, amoxicillin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole, amoxicillin, and clarithromycin (OAC) for 7 days
Trial: 11713443
Drug: Amoxicillin and
RxNorm normalized name: omeprazole, amoxicillin and rifabutin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin and clarithromycin (AC) for 7 days
Trial: 1401761
Drug: Triptoreline 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triptoreline 0.1 mg subcutaneously three times in one day at 8 hour intervals
Trial: 2416164
Drug: Synthetic platelet
RxNorm normalized name: platelet glycoprotein VI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synthetic platelet activating factor (PAF-acether) intradermal injections of 10-100 ng
Trial: 2416164
Drug: Local administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Local administration of H1 antihistamine mepyramin
Trial: 15915393
Drug: Propofol (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (0.5 mg/kg IV followed by titration)
Trial: 15915393
Drug: Midazolam (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (1 mg IV every 2 minutes)
Trial: 10994627
Drug: Child stage
RxNorm normalized name: Senna-Relief Childs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Child stage B/C cirrhosis patients with creatinine > or = 1.4 mg/dl
Trial: 1843597
Drug: Toloxatone (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Toloxatone (400 mg daily for 6 weeks)
Trial: 3922214
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Cytoxan, Hexamethylmelamine, and Fluorouracil (CHF)
Trial: 3922214
Drug: L-phenylalanine mustard
RxNorm normalized name: L-Phenylalanine mustard
DrugBank: Melphalan (DB01042)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L-phenylalanine mustard (L-pam)
Trial: 3922214
Drug: CHF as
RxNorm normalized name: CHF 4227
DrugBank: CHF 4227 (DB05882)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHF as a second-line therapy
Trial: 3922214
Drug: L-pam in
RxNorm normalized name: L-PAM
DrugBank: Melphalan (DB01042)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L-pam in patients with complete resection of less than 2 cm residual disease
Trial: 29224127
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with etanercept and methotrexate